Hence, our study explores the capacity of piperine to manage hyperglycemia by modulating HNF-1α and SREBP-1c expression in an HFD and sucrose-induced insulin resistance/T2DM using an in vivo experimental animal model and in vitro cell line (Chang liver cells) model. This evidence concerns the gene SREBF1 and type 2 diabetes mellitus.